We are monitoring the impact of COVID-19 on Latin America Plasma Protein Therapeutics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 209
Share on
Share on

Latin America Plasma Protein Therapeutics Market Research Report – Segmented By Product Type, Application & Country (Brazil, Mexico, Argentina, Chile and Rest of Latin America) - Industry Analysis, Size, Share, Growth, Trends, Forecast (2021 to 2026)

Pulished: April, 2021
ID: 209
Pages: 135

Latin America Plasma Protein Therapeutics Market Size (2021 to 2026)

The Plasma Protein Therapeutics Market size in Latin America is currently valued at USD 1341.96 Million in 2021. It is forecasted to be a USD 1936.44 Million market by 2026, growing at a significant CAGR of 7.61% between 2021 to 2026.

With the increased production of new plasma-derived therapies, the medical application in plasma proteins has increased significantly. With the advancements in technology, the process for fractionating the protein from plasma has become more cost-saving and efficient and is supposed to boost the plasma protein therapeutics market. According to WHO reports, more than half of the global blood donors belong to high-income countries, constituting 18% of the population. With rising awareness among people regarding blood donations and government initiatives, the plasma-derived medicine market is expected to grow significantly in the coming years.

Plasma is a fluid rich with proteins and plays an important role in providing immunity and blood clotting. Extracting the plasma proteins can help carry out medical therapies for immune deficiencies, autoimmune, bleeding, and neurological disorders. These therapies treat the medical conditions by replacing the missing or deficient proteins in plasma. Through plasma protein therapies, the treatment involves the infusion or injection of biological medicine to cure life-threatening chronic and genetic diseases.

The market is driven by a host of factors, which include increased introduction of new plasma-derived therapies, rise in life-threatening diseases that involve immune and neurological systems like chronic inflammatory demyelinating polyneuropathy (CIPD), Idiopathic thrombocytopenic purpura (ITP), and infectious diseases like Hepatitis A&B, Tetanus, Rabies, and varicella. However, factors like stringent policies by the government and complexity in manufacturing the protein reimbursement must be taken care of for the market to prosper.

This research report on the Latin America Plasma Protein Therapeutics Market has been segmented and sub-segmented into the following categories:

By Type: 

  • Immunoglobulins
  • Albumin
  • Coagulation Factor
  • Alpha-1 Proteinase Inhibitor
  • Others

By Application: 

  • Hemophilia
  • Primary Immunodeficiency Disorder
  • Idiopathic Thrombocytopenic Purpura
  • Secondary Immunodeficiency
  • Others

By Country: 

  • Mexico
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America

The most promising companies in the Latin America Plasma Protein Therapeutics Market profiled in this report are Grifols, CSL Behring, Baxter, Krdrion, China Biologics, Octapharma, Chendu Inst, and Shire Plc.

1. Introduction                                                                                 

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                          

                1.4 General Study Assumptions                                                                

2. Research Methodology                                                                                           

                2.1 Introduction                                                                               

                2.2 Research Phases                                                                      

                                2.2.1 Secondary Research                                                           

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                      

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design                                                                         

                2.4 Study Timeline                                                                          

3. Overview                                                                                       

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 New Developments                                                                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                                    

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                                              

5. Market Segmentation                                                                                              

                5.1 By Type                                                                        

                                5.1.1 Immunoglobulins                                                 

                                5.1.2 Albumin                                                   

                                5.1.3 Coagulation Factors                                                             

                                5.1.4 Alpha-1 proteinase inhibitor                                                            

                                5.1.5 Others                                                      

                5.2 By Application                                                                           

                                5.2.1 Hemophilia                                                             

                                5.2.2 Primary Immunodeficiency Disorder                                                           

                                5.2.3 Idiopathic Thrombocytopenic Purpura                                                        

                                5.2.4 Secondary Immunodeficiency                                                        

                                5.2.5 Others                                                      

6. Geographical Analysis                                                                                              

                6.1 Introduction                                                                               

                6.2 Brazil                                                                             

                6.3 Mexico                                                                         

                6.4 Rest of Latin America                                                                             

7. Strategic Analysis                                                                                       

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

8. Market Leaders' Analysis                                                                                        

                8.1 CSL Behring                                                

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Strategic Evaluation and Operations                                                            

                                8.1.4 Financial analysis                                                  

                                8.1.5 Legal issues                                                             

                                8.1.6 Recent Developments                                                       

                                8.1.7 SWOT analysis                                                       

                                8.1.8 Analyst View                                                          

                8.2 Baxter                                                           

                8.3 Biotest                                                          

                8.4 China Biologics                                                          

                8.5 Grifols                                                           

                8.6 Kedrion                                                        

                8.7 Octapharma                                                               

                8.8 Shire Plc.                                                      

                8.9 Chengdu Inst.                                                            

9. Competitive Landscape                                                                                           

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                                         

                9.4 New Product Launches                                                                         

10. Expert Opinions                                                                                        

                10.1 Market Outlook                                                                     

                10.2 Investment Opportunities                                                                 


                a) List of Tables                                                                

                b) List of Figures                                                                              

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Latin America Plasma Protein Therapeutics Market, By Type, From 2020 to 2025 (USD Million)
  2. Latin America Plasma Protein Therapeutics Market, By Application From 2020 to 2025 (USD Million)
  3. Latin America Immunoglobulins Market, By Region, From 2020 to 2025 (USD Million)
  4. Latin America Albumin Market, By Region, From 2020 to 2025 (USD Million)
  5. Latin America Coagulation Factors Market, By Region, From 2020 to 2025 (USD Million)
  6. Latin America Alpha-1 proteinase inhibitor Market, By Region, From 2020 to 2025 (USD Million)
  7. Latin America Others Market, By Region, From 2020 to 2025 (USD Million)
  8. Latin America Hemophilia Market, By Region, From 2020 to 2025 (USD Million)
  9. Latin America Primary Immunodeficiency Disorder Market, By Region, From 2020 to 2025 (USD Million)
  10. Latin America Idiopathic Thrombocytopenic Purpura Market, By Region, From 2020 to 2025 (USD Million)
  11. Latin America Secondary Immunodeficiency Market, By Region, From 2020 to 2025 (USD Million)
  12. Latin America Others Market, By Region, From 2020 to 2025 (USD Million)
  13. Brazil Plasma Protein Therapeutics Market, By Type, From 2020 to 2025 (USD Million)
  14. Mexico Plasma Protein Therapeutics Market, By Type, From 2020 to 2025 (USD Million)
  15. Rest of Latin America Plasma Protein Therapeutics Market, By Type, From 2020 to 2025 (USD Million)
  16. Brazil Plasma Protein Therapeutics Market, By Application, From 2020 to 2025 (USD Million)
  17. Mexico Plasma Protein Therapeutics Market, By Application, From 2020 to 2025 (USD Million)
  18. Rest of Latin America Plasma Protein Therapeutics Market, By Application From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports


$ 1234 2875

Click for Request Sample